Fundamental dimension Equity attribute | IBPPeer $199.12▲+0.50% Cap $5.29BP/E 21.3x QuantScore40/100 | ALSNPeer $106.32▼-2.97% Cap $8.78BP/E 16.8x QuantScore42/100 | BYDLeader $71.69▼-0.80% Cap $5.21BP/E 10.8x QuantScore54/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
63/100 |
23/100 |
61/100 |
Valuation Multiples, PEG & DCF upside | 36/100 | 76/100 | 75/100 |
Health Piotroski, Altman Z, leverage & liquidity | 55/100 | 26/100 | 28/100 |
Growth Revenue / earnings growth & margins | 15/100 | 30/100 | 31/100 |
Sentiment Analyst ratings, targets & revisions | 33/100 | 53/100 | 74/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 21.3x | 16.8x | 10.8x |
Forward P/E (next FY) | 19.3x | 13.1x | 10.0x |
EV / EBITDA (TTM) | 11.7x | 11.4x | 7.4x |
Price / Sales | 1.8x | 2.4x | 1.3x |
Price / Free Cash Flow | 131.7x | 12.0x | 148.5x |
PEG ratio | 6.42 | -0.58 | -0.15 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 5 / 9 | 6 / 9 |
Altman Z-Score | 4.91 (Safe) | 1.70 (Distress) | 2.22 (Grey) |
Total debt / equity | 1.88 | 2.08 | 1.30 |
Quick ratio | 2.4x | 1.2x | 0.7x |
Interest coverage | 10.2x | 5.6x | 7.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +1.0% | -6.7% | +4.1% |
Net income growth YoY | +3.4% | -14.8% | +218.9% |
Gross margin (TTM) | 33.6% | 39.5% | 30.0% |
Operating margin (FY) | 13.0% | 32.3% | 21.4% |
FCF margin (FY) | 10.1% | 21.6% | 9.5% |
5. Trailing price performancePrice change over period |
1M return | +1.4% | -5.7% | -0.2% |
3M return | -12.4% | -13.1% | -17.6% |
6M return | -34.2% | -21.5% | -14.5% |
Year to date | -23.2% | +8.6% | -15.9% |
1Y return | -25.8% | +28.4% | -9.0% |
3Y return | +79.8% | +85.1% | +17.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $133.14 -33.1% premium | $83.46 -21.5% premium | $411.75 +474.3% upside |
Wall Street consensus target | $216.50 +8.7% · range $160.00–$250.00 | $127.00 +19.5% · range $120.00–$135.00 | $87.70 +22.3% · range $80.00–$103.00 |
Consensus stance | 37% Buy59% Hold4% Sell | 28% Buy52% Hold21% Sell | 64% Buy36% Hold0% Sell |